Outcomes in Patients with Hematological Malignancies Receiving Anti-CD20 Therapy in the Setting of COVID-19 Infection
Facility
NS/LIJ
Department
Division of Hematology/Oncology, Department of Medicine
Status
Fellow
Category
Clinical Science Research
Start Date
2-6-2021 12:00 AM
COinS
Jun 2nd, 12:00 AM
Outcomes in Patients with Hematological Malignancies Receiving Anti-CD20 Therapy in the Setting of COVID-19 Infection